Better understanding of the roles of IGF-binding proteins as potential modulators of the association between IGF1 and breast-cancer risk might come from further data on IGFBP1 and IGFBP2, from measures of intact IGFBP3,54 or from measures of bioavailable IGF1.55 This evidence concerns the gene IGFBP1 and breast cancer.